Timing of Synairgen Phase III nebulised Covid-19 treatment remains a challenge
There are also concerns surrounding Synairgen SNG001’s potential inflammatory effects in advanced Covid-19.
Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate...
SyneuRx to recruit 500–1,000 patients for oral Covid-19 antiviral Phase III test
The US-based Phase III will likely use electronic Patient Report Outcome (ePRO) tools to report symptoms.
Regulatory roundup: Invokana approval shot increases in heart failure with positive Phase III data
Merck KGaA in schistosomiasis and Jupiter Wellness in first-degree burns are also reviewed by GlobalData’s Investigative News team.
Eileen O’Reilly: how pancreatic cancer disease burden can stymie enrolment momentum
A dip in survival among pancreatic cancer patients is anticipated in the coming years due to the pandemic.
Latest Deals
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
Weekly chart
Countries with digitalization jobs growth in clinical trial operations in the three months to September
Source: GlobalData
| Country | July-Sept YoY AI jobs growth (%) |
|---|---|
| United States | 7.7 |
| France | 0.1 |
Latest News
J&J’s Covid-19 booster shot offers greater antibody responses
J&J’s booster given after Pfizer-BioNTech’s two-dose regimen led to a continued rise of antibodies for a minimum of four weeks.
FDA approves InteRNA Technologies’ Phase I solid tumour treatment study
The Phase I/Ib trial will assess the pharmacodynamics, pharmacokinetics, preliminary efficacy, and safety of INT-1B3.
Acasti Pharma reports positive interim data from SAH therapy trial
The trial will compare and assess GTX-104’s relative bioavailability with the oral nimodipine capsules.
Hepagene begins Phase IIa clinical trial of HPG1860 to treat NASH
The Phase IIa clinical trial will assess the tolerability, efficacy, and safety of HPG1860.
Latest Themes
Filings buzz in pharma: 16% decrease in big data mentions in Q2
The frequency of sentences related to big data between July 2020 and June 2021 was 71% higher than in 2016.
Filings buzz: tracking cybersecurity mentions in pharmaceuticals
Mentions of cybersecurity in the pharmaceutical industry fell 34% between the first and second quarters of 2021.
Artificial intelligence innovation among clinical trial operations industry companies rebounded in the last quarter
Recent figures show the number of AI patent applications in the industry stood at 72 in the three months ending September.
North America is seeing a hiring boom in clinical trial operations industry big data roles
North America keeps its dominance in big data hiring in the clinical trial operations industry in the three months ending September.
Europe is seeing a hiring boom in clinical trial operations industry robotics roles
Europe was the fastest growing region for robotics hiring among clinical trial operations industry companies in the three months ending September.
Filings buzz in pharmaceuticals: 19% increase in digitalization mentions in Q2 of 2021
Digitalization mentions within company filings in the pharmaceutical industry rose 19% between Q1 and Q2 of 2021.
Industrial automation hiring levels in the clinical trial operations industry rose in October 2021
Some 53.2% of the companies included in our analysis recruited for at least one industrial automation related position in October 2021 compared with the equivalent month last year.
BYJU’s, India’s most valuable unicorn, is giving the UK an education in AI technology
Byju’s expansion comes to the UK with an innovation hub exploring AI technology in education.
Expert Commentary & Analysis
View MoreHypoglycemia market is saturated, but opportunity remains for preventative treatments
Over the next 10 years, the hypoglycemia market is expected to almost completely transition from...
Encouraging pipeline for DMD patients
DMD's inheritance pattern is X-linked recessive and is caused by mutations on the gene that...
The changing dynamics of clinical trial country distribution: 2016–2021
Countries with the most trial initiations between 2016 and 2021 include the US, China, India,...
Increase in prostate cancer screening after rollout of revised national guidelines
GlobalData epidemiologists expect that the rise in prostate cancer screening may lead to an increase...